eBook: Top 10 Orphan Drug Pipelines in Europe 13 June 2013 / By Matt Turner / Clinical Trials, Orphan Drugs, Partnering & Investment / 0 comments
Download: Optimising Clinical Development & Speeding Patient Access to Orphan Drugs 5 June 2013 / By Matt Turner / Clinical Trials, Market Access, Orphan Drugs, Partnering & Investment / 0 comments
Whitepapers: Challenges Faced in Rare Disease Product Development & The Role of a Patient Association 8 May 2013 / By Matt Turner / Clinical Trials, Orphan Drugs, Partnering & Investment / 0 comments
5 Speakers Not to Miss at this Month’s World Stem Cells & Regenerative Medicine Congress in London 7 May 2013 / By Matt Turner / Clinical Trials, Regenerative Medicine / 0 comments
Download the Provisional Attendee List for the World Stem Cells & Regenerative Medicine Congress 2013 7 May 2013 / By Matt Turner / Partnering & Investment, Regenerative Medicine / 0 comments
Presentation: Stratified medicine in a dish using human induced pluripotent stem cells 30 April 2013 / By Matt Turner / Cell Culture, Regenerative Medicine / 0 comments
5 Leading Presentations from the 7th Annual World Stem Cells & Regenerative Medicine Congress 29 April 2013 / By Matt Turner / Clinical Trials, Regenerative Medicine / 2 comments
Top 5 Presentations from Last year’s World Orphan Drug Congress Europe 25 April 2013 / By Matt Turner / Market Access, Orphan Drugs, Partnering & Investment, Regulation and Government / 0 comments
2013 Rare & Orphan Advocacy and Research (ROAR) Awards – VOTING NOW OPEN 23 April 2013 / By Matt Turner / Featured on app, Orphan Drugs, Reports / 0 comments
Guest Blog – Social media and stem cells: Time to start tweeting 22 April 2013 / By Matt Turner / Regenerative Medicine / 0 comments
